Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020

SELL
$7.99 - $37.6 $7.99 Million - $37.6 Million
-1,000,000 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$32.69 - $47.91 $21.2 Million - $31.1 Million
-650,000 Reduced 39.39%
1,000,000 $38.9 Million
Q4 2018

Feb 14, 2019

BUY
$37.1 - $50.11 $2.2 Million - $2.98 Million
59,400 Added 3.73%
1,650,000 $69.4 Million
Q2 2018

Aug 14, 2018

BUY
$33.85 - $50.65 $8.14 Million - $12.2 Million
240,600 Added 17.82%
1,590,600 $60.8 Million
Q1 2018

May 15, 2018

BUY
$32.45 - $54.7 $26 Million - $43.8 Million
800,000 Added 145.45%
1,350,000 $54.1 Million
Q4 2017

Feb 14, 2018

BUY
$21.8 - $39.35 $12 Million - $21.6 Million
550,000
550,000 $19.3 Million

Others Institutions Holding WVE

About Wave Life Sciences Ltd.


  • Ticker WVE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,820,096
  • Market Cap $720M
  • Description
  • Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...
More about WVE
Track This Portfolio

Track Boxer Capital, LLC Portfolio

Follow Boxer Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boxer Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boxer Capital, LLC with notifications on news.